Arthritis drug ‘effective in treating critically ill Covid-19 patients’

(Peter Byrne/PA)

A drug used to treat rheumatoid arthritis can improve clinical outcomes of critically ill patients with Covid-19, early results suggest.

Tocilizumab, a medicine that suppresses the immune system and reduces inflammation, has been shown to be effective in treating patients in intensive care units (ICU) with severe Covid-19.